The Kidney and Hypertension in Diabetes Mellitus Book

1	Rationale for early screening for diabetic renal disease	1
2	Pressure-induced and metabolic alterations in the glomerulus : cytoskeletal changes	13
3	The Steno hypothesis for cardiovascular and renal disease revisited	27
4	Microalbuminuria and cardiovascular disease	45
5	The heart in diabetes : results of trials	63
6	Microalbuminuria and GFR in type 1 and type 2 diabetes	77
7	Serum creatinine and other measures of GFR in diabetes	107
8	Familiai factors in diabetic nephropathy	117
9	Genetics and diabetic nephropathy	129
10	Low birth weight and diabetic nephropathy	149
11	Effects of insulin on the cardiovascular system and the kidney	163
12	Value of screening for microalbuminuria in people with diabetes as well as in the general population	181
13	Dysfunction of the vascular endothelium and the development of renal and vascular complications in diabetes	197
14	Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus	223
15	Pathology of the kidney in diabetes mellitus	241
16	Renal structural changes in patients with type 1 diabetes and microalbuminuria	255
17	Renal structure in type 2 diabetes	271
18	Nephropathy in type 2 diabetic patients, predictors of outcome	287
19	Advanced glycation end-products and diabetic renal disease	303
20	Protein kinase C activation and its inhibition for the treatment of diabetic renal pathologies	323
21	Biochemical aspects of diabetic nephropathy	341
22	Pathogenesis of diabetic glomerulopathy : the role of glomerular hemodynamic factors	363
23	The emerging role of growth factor hormone (GH) and vascular endothelial growth factor (VEGF) in diabetic kidney disease	383
24	Transforming growth factor-[beta] and other cytokines in experimental and human diabetic nephropathy	397
25	Blood pressure elevation in diabetes : the results from 24-h ambulatory blood pressure recordings	433
26	Microalbuminuria in young patients with type 1 diabetes	457
27	Early renal hyperfunction and hypertrophy in IDDM, including comments on early intervention	479
28	Autoregulation of glomerular filtration rate in patients with diabetes	495
29	The role of renal biopsy in the clinic	515
30	Inhibition of the renin angiotensin aldosterone system, with particular reference to the dual blockade principle	527
31	The concept of incipient diabetic nephropathy and the effect of early antihypertensive intervention	541
32	The role of proteinuria in the diagnosis and treatment of type 2 diabetes	555
33	Antihypertensive treatment in type 2 diabetes, with special reference to abnormal albuminuria : a focus on the new trials	579
34	Blood pressure lowering treatment and the prevention of stroke in the diabetic patient	611
35	Non-glycaemic intervention in diabetic nephropathy : the role of dietary protein and salt intake	631
36	Diabetic nephropathy and pregnancy	647
37	Evolution worldwide of renal replacement therapy in diabetes	687
38	Hemodialysis and CAPD in type 1 and type 2 diabetic patients with endstage renal failure	703
39	Renal and pancreas transplants in diabetes	725
40	Combination therapy for hypertension and renal disease in diabetes	767
41	Microalbuminuria in essential hypertension : cardiovascular and renal implications	785
42	A comparison of progression in diabetic and non-diabetic renal disease : similarity of progression promoters	801
43	Scientific basis for new guidelines for the treatment of hypertension in type 2 diabetes	821
44	Regulatory considerations in the development of therapies for diabetic nephropathy and related conditions	837
45	Diabetes, hypertension, and kidney disease in the Pima Indians	857
46	The development and progression of clinical nephropathy in white patients with type 2 diabetes	871
47	Microalbuminuria, blood pressure and diabetic renal disease : origin and development of ideas	883